Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Intravitreal Injection of Bevacizumab in Combination With Verteporfin Photodynamic Therapy

NCT00347399 is registered in ClinicalTrials.gov with Asociación para Evitar la Ceguera en México as lead sponsor.

NCT NCT00347399
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00347399 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Intravitreal Injection of Bevacizumab in Combination With Verteporfin Photodynamic Therapy
Lead sponsor
Asociación para Evitar la Ceguera en México
Phase
Phase 2
Overall status
Terminated
Start date
March 31, 2006
Completion date
June 30, 2007
Enrollment
25 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

age related macular degeneration